NEUTROGENA COMPLETE ACNE THERAPY SOLUTION- salicylic acid, avobenzone, octisalate, octocrylene, oxybenzone, and benzoyl peroxide kit
Neutrogena Complete Acne Therapy Solution by
Drug Labeling and Warnings
Neutrogena Complete Acne Therapy Solution by is a Otc medication manufactured, distributed, or labeled by Johnson & Johnson Consumer Inc.. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
- SPL UNCLASSIFIED SECTION
- Active ingredient
- Purpose
- Use
-
Warnings
For external use only
- Directions
-
Other information
Sunburn Alert: this product contains an alpha hydroxy acid (AHA) that may increase your skin's sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing and limit sun exposure while using this product and for a week afterwards. Store at room temperature.
-
Inactive ingredients
water, cetyl alcohol, PPG-15, stearyl ether, glycolic acid, glycerin, polysorbate 60, steareth-21, C12-15 alkyl lactate, cetyl lactate, potassium cetyl phosphate, sodium hydroxide, xanthan gum, cocamidopropyl PG-dimonium chloride phosphate, disodium EDTA, menthol, fragrance, benzalkonium chloride, panthenol
- Questions?
- SPL UNCLASSIFIED SECTION
- Active ingredient
- Purpose
-
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
- Warnings
-
Directions
For sunscreen use
- apply liberally and evenly 15 minutes before sun exposure
- reapply at least every 2 hours.
- use a water resistant sunscreen if swimming or sweating
-
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging . To decrease this risk, regularly use a sunscreen with a Broad Spectrum value of SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeved shirts, pants, hats, and sunglasses
- Children under 6 months of age: Ask a doctor
- Other information
- Inactive ingredients
- Questions?
- SPL UNCLASSIFIED SECTION
- Active ingredient
- Purpose
- Use
-
Warnings
For external use only
- When using this product
- skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
When using this product
- avoid unnecessary sun exposure and use a sunscreen
- avoid contact with the eyes, lips and mouth.
- avoid contact with hair or dyed fabrics, which may be bleached by this product.
- Skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.
-
Directions
- Clean the skin thoroughly before applying this product.
- Cover the entire affected area with a thin layer one to three times daily.
- because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
- If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
- Inactive ingredients
- Questions?
- SPL UNCLASSIFIED SECTION
-
PRINCIPAL DISPLAY PANEL - Kit Carton
NEW FORMULA
approximately 2 months supply
CLINICALLY
PROVEN
overnight results
with acne
control lotioncomplete acne therapy
solutionReduces size and redness overnight without over-drying skin
Controls breakouts with 2 dermatologist recommended medicinesNeutrogena®
oil-free moisture with sunscreen acne control lotion with skin polishing acne cleanser Broad Spectrum SPF 15 benzoyl peroxide acne medicine with salicylic acid acne treatment 1.7 FL. OZ. (50mL) 1.4 FL. OZ. (40mL) 5.1 FL.OZ. (150mL) 
-
INGREDIENTS AND APPEARANCE
NEUTROGENA COMPLETE ACNE THERAPY SOLUTION
salicylic acid, avobenzone, octisalate, octocrylene, oxybenzone, and benzoyl peroxide kitProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC: 69968-0074 Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC: 69968-0074-9 1 in 1 CARTON 10/01/2016 Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 1 TUBE 150 mL Part 2 1 TUBE 50 mL Part 3 1 TUBE 40 mL Part 1 of 3 NEUTROGENA SKIN POLISHING ACNE CLEANSER
salicylic acid creamProduct Information Item Code (Source) NDC: 69968-0320 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ) Salicylic Acid 20 mg in 1 mL Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Sodium Methyl Cocoyl Taurate (UNII: JVL98CG53G) Cocamidopropyl Betaine (UNII: 5OCF3O11KX) Sodium Chloride (UNII: 451W47IQ8X) Glycol Distearate (UNII: 13W7MDN21W) High Density Polyethylene (UNII: UG00KM4WR7) Glycolic Acid (UNII: 0WT12SX38S) Sodium Lactate (UNII: TU7HW0W0QT) Cocamidopropyl Propylene Glycol-Dimonium Chloride Phosphate (UNII: H2KVQ74JM4) Polyquaternium-11 (1000000 MW) (UNII: 0B44BS5IJS) Edetate Disodium Anhydrous (UNII: 8NLQ36F6MM) Citric Acid Monohydrate (UNII: 2968PHW8QP) Sodium Hydroxide (UNII: 55X04QC32I) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC: 69968-0320-5 150 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part333D 12/14/2016 Part 2 of 3 NEUTROGENA OIL FREE MOISTURE BROAD SPECTRUM SPF15
avobenzone, octisalate, octocrylene, and oxybenzone lotionProduct Information Item Code (Source) NDC: 10812-979 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Avobenzone (UNII: G63QQF2NOX) (Avobenzone - UNII:G63QQF2NOX) Avobenzone 15 mg in 1 mL Octisalate (UNII: 4X49Y0596W) (Octisalate - UNII:4X49Y0596W) Octisalate 50 mg in 1 mL Octocrylene (UNII: 5A68WGF6WM) (Octocrylene - UNII:5A68WGF6WM) Octocrylene 30 mg in 1 mL Oxybenzone (UNII: 95OOS7VE0Y) (Oxybenzone - UNII:95OOS7VE0Y) Oxybenzone 40 mg in 1 mL Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Octyldodecyl Neopentanoate (UNII: X8725R883T) Glycerin (UNII: PDC6A3C0OX) Glyceryl Monostearate (UNII: 230OU9XXE4) PEG-100 Stearate (UNII: YD01N1999R) Dimethicone (UNII: 92RU3N3Y1O) Phenoxyethanol (UNII: HIE492ZZ3T) Ethylhexylglycerin (UNII: 147D247K3P) Caprylyl Glycol (UNII: 00YIU5438U) Carboxypolymethylene (UNII: 0A5MM307FC) Trolamine (UNII: 9O3K93S3TK) Methylparaben (UNII: A2I8C7HI9T) Edetate Disodium Anhydrous (UNII: 8NLQ36F6MM) Ethylene Brassylate (UNII: 9A87HC7ROD) Dipropylene Glycol (UNII: E107L85C40) 2,6-Dimethyl-5-Heptenal (UNII: Z331YX9EL9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC: 10812-979-03 50 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/15/2014 Part 3 of 3 NEUTROGENA ACNE CONTROL
benzoyl peroxide lotionProduct Information Item Code (Source) NDC: 10812-975 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Benzoyl Peroxide (UNII: W9WZN9A0GM) (Benzoyl Peroxide - UNII:W9WZN9A0GM) Benzoyl Peroxide 25 mg in 1 mL Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Carbomer Homopolymer Type B (Allyl Pentaerythritol or Allyl Sucrose Crosslinked) (UNII: K6MOM3T5YL) Ethylhexylglycerin (UNII: 147D247K3P) Sodium Hydroxide (UNII: 55X04QC32I) Chlorphenesin (UNII: I670DAL4SZ) Edetate Disodium Anhydrous (UNII: 8NLQ36F6MM) Laureth-4 (UNII: 6HQ855798J) Hypromellose, Unspecified (UNII: 3NXW29V3WO) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC: 10812-975-01 40 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part333D 03/14/2014 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part333D 10/01/2016 Labeler - Johnson & Johnson Consumer Inc. (002347102)
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.